Literature DB >> 27476150

Surgical intervention and perioperative risk factors of retroperitoneal teratomas in children: a single institution experience.

Shigehisa Fumino1, Junnosuke Maniwa1, Yuki Takeuchi1, Kohei Sakai1, Mayumi Higashi1, Shigeyoshi Aoi1, Taizo Furukawa1, Osamu Kimura1, Tatsuro Tajiri2.   

Abstract

PURPOSE: Retroperitoneal teratomas (RTs) are rare among germ cell tumors and predominantly occur in infants. RTs are often difficult to manage by perioperative management. In this study, we retrospectively reviewed our series of RTs.
METHODS: Seventy patients with germ cell tumors were treated from 1989 to 2015 in our institution. Fourteen patients had RTs (3 boys and 11 girls). The median age at diagnosis was 5.5 months (range 0-64), and three were antenatally diagnosed.
RESULTS: All except one patient underwent total tumor excision. They exhibited dense adhesions with major vessels, and ligation of the splenic and gastroduodenal arteries was required in two patients. Injuries of PV and renal artery occurred in two patients. IVC injury in a neonate with a giant mass caused circulatory failure and brain death occurred postoperatively. Other major complications included injury of the diaphragm and bile duct. An infant whose tumor compressed the superior mesenteric artery developed enteritis while waiting for surgery and non-occlusive mesenteric ischemia, resulting in massive intestinal necrosis. The perioperative complication rate was 50 %.
CONCLUSION: Surgery for RTs remains challenging, and a preoperative evaluation of the vascular anatomy is crucial due to the high complication rate. Moreover, pre- and intraoperative fluid management is important to avoid any unexpected fatalities.

Entities:  

Keywords:  Down syndrome; Mesenteric ischemia; Perioperative management; Retroperitoneal teratoma; Surgical complication

Mesh:

Year:  2016        PMID: 27476150     DOI: 10.1007/s00383-016-3938-6

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  6 in total

Review 1.  Operative considerations in pediatric retroperitoneal teratomas--a review.

Authors:  Vinci S Jones; Cartland R Burns
Journal:  Eur J Pediatr Surg       Date:  2012-07-07       Impact factor: 2.191

Review 2.  Mesenteric Ischemia.

Authors:  Daniel G Clair; Jocelyn M Beach
Journal:  N Engl J Med       Date:  2016-03-10       Impact factor: 91.245

3.  Increased incidence of retroperitoneal teratomas and decreased incidence of sacrococcygeal teratomas in infants with Down syndrome.

Authors:  Tetsuko Kobayashi; Yoshihiro Sakemi; Hironori Yamashita
Journal:  Pediatr Blood Cancer       Date:  2013-07-31       Impact factor: 3.167

4.  Retroperitoneal teratomas--potential for surgical misadventure.

Authors:  Niall M Jones; Edward M Kiely
Journal:  J Pediatr Surg       Date:  2008-01       Impact factor: 2.545

Review 5.  Primary retroperitoneal teratomas: a review of the literature.

Authors:  Heather G Gatcombe; Vasily Assikis; David Kooby; Peter A S Johnstone
Journal:  J Surg Oncol       Date:  2004-05-01       Impact factor: 3.454

Review 6.  Retroperitoneal cystic masses: CT, clinical, and pathologic findings and literature review.

Authors:  Dal Mo Yang; Dong Hae Jung; Hana Kim; Jee Hee Kang; Sun Ho Kim; Ji Hye Kim; Hee Young Hwang
Journal:  Radiographics       Date:  2004 Sep-Oct       Impact factor: 5.333

  6 in total
  2 in total

1.  Case Reports: Management Challenges in Pediatric Germ Cell Tumors.

Authors:  Sophie Carr; Arash Safavi; Erik D Skarsgard
Journal:  Front Pediatr       Date:  2021-04-15       Impact factor: 3.418

2.  Retroperitoneal teratomas in children: a single institution experience.

Authors:  Takafumi Kawano; Koshiro Sugita; Chihiro Kedoin; Ayaka Nagano; Mayu Matsui; Masakazu Murakami; Masato Kawano; Keisuke Yano; Shun Onishi; Toshio Harumatsu; Koji Yamada; Waka Yamada; Ryuta Masuya; Makoto Matsukubo; Mitsuru Muto; Seiro Machigashira; Kazuhiko Nakame; Motoi Mukai; Tatsuru Kaji; Satoshi Ieiri
Journal:  Surg Today       Date:  2021-06-19       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.